Your institution may have access to this item. Find your institution then sign in to continue.
Title
First stem cell-derived islets in humans.
Abstract
The article reports on the approval of the U.S. Food and Drug Administration (FDA) for San Diego, California-based regenerative medicine company Viacyte Inc. to evaluate its insulin-making cell pouch in humans.